BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
Clinical trial NCT03496662 · COMPLETED
Trial details
- NCT number
- NCT03496662
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-31
- Primary completion
- 2021-10-28
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.